The PsoTeenQOL - Preliminary Reliability and Validity

NCT03358914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233

Last updated 2019-04-24

No results posted yet for this study

Summary

This study aims to develop and provide preliminary reliability and validity of a questionnaire to measure Health-related Quality of Life (HRQOL) in adolescents with psoriasis. To the best of our knowledge, this will be the first psoriasis-specific HRQOL instrument for use in adolescent patients. Data will be collected from a Danish population of adolescents with psoriasis (12-17 years), as well as from parents of adolescents with psoriasis, and a group of adolescents without psoriasis.

Conditions

Interventions

OTHER

No intervention

Completion of surveys

Sponsors & Collaborators

  • Herlev and Gentofte Hospital

    collaborator OTHER
  • LEO Pharma

    collaborator INDUSTRY
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Hilde Randa · University of Aarhus

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2019-01-15
Completion
2019-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03358914 on ClinicalTrials.gov